This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Estia Health Croissance future

Future contrôle des critères 4/6

Estia Health devrait augmenter ses bénéfices et son chiffre d'affaires de 67% et de 7% par an respectivement. Le BPA devrait croître de de 86.5% par an. Le rendement des capitaux propres devrait être 9.5% dans 3 ans.

Informations clés

67.0%

Taux de croissance des bénéfices

86.5%

Taux de croissance du BPA

Healthcare croissance des bénéfices	26.5%
Taux de croissance des recettes	7.0%
Rendement futur des capitaux propres	9.5%
Couverture par les analystes	Low
Dernière mise à jour	06 Dec 2023

Mises à jour récentes de la croissance future

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

Prévisions de croissance des bénéfices et des revenus

ASX:EHE - Estimations futures des analystes et données financières antérieures (AUD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2026	976	49	N/A	167	3
6/30/2025	941	46	94	149	4
6/30/2024	870	-19	101	172	4
6/30/2023	754	-34	126	187	N/A
3/31/2023	721	-52	75	130	N/A
12/31/2022	689	-70	24	73	N/A
9/30/2022	680	-61	23	64	N/A
6/30/2022	671	-52	22	56	N/A
3/31/2022	668	-25	54	87	N/A
12/31/2021	665	3	86	118	N/A
9/30/2021	656	4	47	86	N/A
6/30/2021	646	6	7	55	N/A
3/31/2021	645	-66	11	66	N/A
12/31/2020	643	-137	14	77	N/A
9/30/2020	640	-127	30	102	N/A
6/30/2020	637	-117	45	126	N/A
3/31/2020	625	-41	27	113	N/A
12/31/2019	612	35	8	101	N/A
9/30/2019	599	38	1	94	N/A
6/30/2019	586	41	-6	88	N/A
3/31/2019	575	42	7	96	N/A
12/31/2018	565	42	20	105	N/A
9/30/2018	556	42	49	121	N/A
6/30/2018	547	41	78	137	N/A
3/31/2018	540	41	85	138	N/A
12/31/2017	533	41	92	139	N/A
9/30/2017	529	41	91	139	N/A
6/30/2017	525	41	90	139	N/A
3/31/2017	517	36	N/A	148	N/A
12/31/2016	510	31	N/A	158	N/A
9/30/2016	476	29	N/A	150	N/A
6/30/2016	443	28	N/A	142	N/A
3/31/2016	400	27	N/A	146	N/A
12/31/2015	357	27	N/A	150	N/A
9/30/2015	321	2	N/A	127	N/A
6/30/2015	285	-23	N/A	104	N/A
3/31/2015	228	-30	N/A	71	N/A
12/31/2014	171	-38	N/A	38	N/A
9/30/2014	119	-26	N/A	24	N/A
6/30/2014	67	-14	N/A	10	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: EHE devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.1% ).

Bénéfices vs marché: EHE devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: EHE devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de EHE ( 7% par an) devrait croître plus rapidement que le marché Australian ( 5.4% par an).

Croissance élevée des revenus: Le chiffre d'affaires de EHE ( 7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de EHE devrait être faible dans 3 ans ( 9.5 %).

This company listing is no longer active

Estia Health Croissance future

Future contrôle des critères 4/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 30%, revenue upgraded

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Consensus EPS estimates fall by 22%, revenue upgraded

Consensus forecasts updated

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance